## **Core Concept**
Eale's disease is a rare, idiopathic condition characterized by recurrent retinal and vitreous hemorrhages, retinal ischemia, and neovascularization, primarily affecting young adults. The exact pathogenesis is unknown, but it is believed to involve an abnormal immune response and hypersensitivity reaction. The treatment aims to manage symptoms, prevent complications, and preserve vision.

## **Why the Correct Answer is Right**
The correct answer, **C. Corticosteroids and laser photocoagulation**, is the treatment of choice because corticosteroids help reduce inflammation, which is thought to play a role in the disease process, while laser photocoagulation is used to treat retinal neovascularization and ischemia. This combined approach can help prevent further hemorrhages and promote absorption of existing hemorrhages, thereby preserving vision.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Anti-vascular endothelial growth factor (anti-VEGF) therapy may be considered in some cases for its anti-angiogenic properties, but it is not the first-line treatment for Eale's disease.
- **Option B:** Intravitreal antibiotics are not indicated in the treatment of Eale's disease as there is no evidence of bacterial infection.
- **Option D:** Observation alone would not be appropriate as Eale's disease requires active treatment to prevent vision loss from recurrent hemorrhages and neovascularization.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Eale's disease often presents unilaterally but can affect the other eye. Early diagnosis and treatment are crucial to prevent severe vision loss. The use of **laser photocoagulation** to treat areas of retinal ischemia and neovascularization is particularly effective in reducing the risk of future complications.

## **Correct Answer:** C. Corticosteroids and laser photocoagulation